GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (LTS:0A57) » Definitions » Equity-to-Asset

T2 Biosystems (LTS:0A57) Equity-to-Asset : -0.65 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is T2 Biosystems Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. T2 Biosystems's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-11.71 Mil. T2 Biosystems's Total Assets for the quarter that ended in Sep. 2024 was $18.08 Mil. Therefore, T2 Biosystems's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was -0.65.

The historical rank and industry rank for T2 Biosystems's Equity-to-Asset or its related term are showing as below:

LTS:0A57' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.53   Med: -0.02   Max: 0.67
Current: -0.65

During the past 12 years, the highest Equity to Asset Ratio of T2 Biosystems was 0.67. The lowest was -1.53. And the median was -0.02.

LTS:0A57's Equity-to-Asset is ranked worse than
94.25% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.625 vs LTS:0A57: -0.65

T2 Biosystems Equity-to-Asset Historical Data

The historical data trend for T2 Biosystems's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Equity-to-Asset Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.19 0.11 -0.21 -1.16 -0.81

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.81 -1.53 -0.27 -0.65

Competitive Comparison of T2 Biosystems's Equity-to-Asset

For the Diagnostics & Research subindustry, T2 Biosystems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Equity-to-Asset falls into.


;
;

T2 Biosystems Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

T2 Biosystems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-28.036/34.797
=-0.81

T2 Biosystems's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=-11.71/18.082
=-0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


T2 Biosystems  (LTS:0A57) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


T2 Biosystems Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines